Table 3. Univariate analysis of survival in radically operated pancreatic adenocarcinoma patients.

	Median survival (months)	95% CI	P-value
Gender
Female	13.00	7.99–18.01	0.4020
Male	19.00	13.40–24.60
Age
<65 years	12.00	10.23–13.77	0.2890
>65 years	22.00	16.36–27.64
T factor
T1–2	21.00	4.71–37.29	0.4360
T3	16.00	11.67–20.33
N factor
N0	24.00	9.12–34.88	0.0202
N+	13.00	9.70–16.30
Adjuvant therapy
No adjuvant therapy	15.00	12.33–19.34	P=0.2048
Any adjuvant therapy	22.00	13.67–28.11
Nuclear Survivin expression
Survivin negative	10.00	10.34–13.66	0.0009
Survivin positive	27.00	20.03–31.97
Cytoplasmic Survivin expression
Survivin negative	25.00	8.87–29.66	0.0127
Survivin positive	10.00	7.34–17.65
Cox-2 expression
Cox-2 negative	18.00	8.07–27.93	0.657
Cox-2 positive	17.00	10.83–23.17
TUNEL staining
TUNEL <10	24.00	14.42–25.58	0.0142
TUNEL >10	11.00	2.55–13.45